Insider filing · GILD
Kelly A. Kramer
Director
profile →
Gilead Sciences, Inc.
GILD · Healthcare · 88 filings in 24 months
ticker →
Kelly A. Kramer sold $713K of Gilead Sciences (GILD)
Executed Nov 26 2025, disclosed Dec 1 2025, 5 days later.
Value, as filed
$713K
5,611 sh across 2 lots
Executed
Nov 26 2025
the trade date, as filed
Disclosed
Dec 1 2025
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KKKelly A. Kramer (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $713K of GILD (5,611 sh across 2 lots, as filed), executed Nov 26 2025.
The name
GILDHealthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→